Retrieve available abstracts of 7 articles: HTML format
Single Articles
October 2025
GUREVICH-SHAPIRO A, Zwicky P, Winter E, Zada M, et al Distinct cellular and molecular patterns in pre-treatment peripheral blood are
associated with CAR-T cell outcomes in diffuse large B-cell lymphoma.
Cancer Res. 2025 Oct 10. doi: 10.1158/0008-5472.CAN-25-3596. PubMedAbstract available
July 2025
MANARA P, Newsam AD, Venkatarame Gowda Saralamma V, Cunningham TA, et al Blocking NRF2 Translation by Inhibition of Cap-Dependent Initiation Sensitizes
Lymphoma Cells to Ferroptosis and CAR T-cell Immunotherapy.
Cancer Res. 2025 Jul 31. doi: 10.1158/0008-5472.CAN-24-3420. PubMedAbstract available
May 2024
ZHU J, Wang F, Wang L, Dai B, et al HDAC Inhibition Increases CXCL12 Secretion to Recruit Natural Killer Cells in
Peripheral T Cell Lymphoma.
Cancer Res. 2024 May 8. doi: 10.1158/0008-5472.CAN-23-3250. PubMedAbstract available
April 2024
ITO Y, Marouf A, Kogure Y, Koya J, et al Comprehensive genetic profiling reveals frequent alterations of driver genes on
the X chromosome in extranodal NK/T-cell lymphoma.
Cancer Res. 2024 Apr 24. doi: 10.1158/0008-5472.CAN-24-0132. PubMedAbstract available
XU X, Zhang Y, Lu Y, Zhang X, et al CD58 alterations govern antitumor immune responses by inducing PD-L1 and IDO in
diffuse large B-cell lymphoma.
Cancer Res. 2024 Apr 18. doi: 10.1158/0008-5472.CAN-23-2874. PubMedAbstract available
January 2024
MARULLO R, Rutherford SC, Revuelta MV, Zamponi N, et al XPO1 Enables Adaptive Regulation of mRNA Export Required for Genotoxic Stress
Tolerance in Cancer Cells.
Cancer Res. 2024;84:101-117. PubMedAbstract available
October 2023
KNITTEL G, Reinhardt HC XPO1-mediated mRNA export of genome maintenance regulators drives chemotherapy
resistance in aggressive lymphoma.
Cancer Res. 2023 Oct 30. doi: 10.1158/0008-5472.CAN-23-2966. PubMedAbstract available